Penny Toren

Insider Reports History

Identity 1 identity field
Location
Philadelphia, PA
SEC source record 1 source field
Owner filing signature
/s/ David Baker, attorney-in-fact
Source evidence 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Penny Toren

Form 4 holding SVP, Regul Affairs & Prog Mgmt

Vallon Pharmaceuticals, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
25,000
Estimated value
$17,143
Report date
14 May 2021
Price
$0.6857
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Penny Toren

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .